Production (Stage)
Fresenius Medical Care AG
FMS
$29.02
$0.48711.71%
NYSE
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 27.10% | 8.22% | 49.23% | -7.53% | -15.90% |
| Total Depreciation and Amortization | -11.14% | -12.62% | -13.14% | -12.87% | -6.87% |
| Total Amortization of Deferred Charges | -7.63% | -7.63% | 8.87% | 3.23% | -0.52% |
| Total Other Non-Cash Items | -197.12% | 76.15% | -85.46% | 46.33% | 169.35% |
| Change in Net Operating Assets | 3.06% | -21.22% | -28.89% | -40.49% | 832.01% |
| Cash from Operations | -7.72% | -9.37% | -8.11% | -12.25% | 27.22% |
| Capital Expenditure | -4.16% | -2.08% | -8.99% | -2.47% | -0.15% |
| Sale of Property, Plant, and Equipment | -31.93% | -13.56% | -41.94% | -19.02% | -44.09% |
| Cash Acquisitions | -530.91% | 81.33% | -103.11% | -90.06% | -95.46% |
| Divestitures | 203.45% | 264.91% | 2,124.06% | 1,358.80% | 251.71% |
| Other Investing Activities | -530.14% | 33.67% | 79.06% | 112.80% | 105.89% |
| Cash from Investing | 72.20% | 83.71% | 89.82% | 100.71% | 31.98% |
| Total Debt Issued | -110.19% | -69.72% | -82.66% | -103.29% | -63.81% |
| Total Debt Repaid | 14.54% | -19.07% | -44.19% | 24.77% | -4.28% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -5.06% | -5.06% | -5.06% | -5.06% | 15.10% |
| Other Financing Activities | -24.72% | -7.81% | 15.23% | 18.53% | 1.89% |
| Cash from Financing | -11.58% | -37.48% | -90.65% | -77.32% | -66.20% |
| Foreign Exchange rate Adjustments | 117.49% | 134.95% | 64.63% | 84.22% | 27.33% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -243.58% | -249.86% | -140.13% | -176.74% | -177.97% |